These novel immune signatures identify patients most at risk for developing severe COVID-19 symptoms.
Using flow cytometry, researchers have developed a sensitive and specific test for COVID-19 that can identify asymptomatic carriers.
Serology testing may be fast and easy to perform, but there are still some limitations that need to be overcome, suggests Laurent Renia.
A new test manufactured by A*STAR’s Diagnostics Development Hub in partnership with Duke-NUS Medical School could reveal if an individual is likely immune to COVID-19.
A biosensor designed with quantum properties is 15 times more sensitive than classical sensors.
In a display of scientific willpower, A*STAR researchers developed and deployed the COVID-19 diagnostic Fortitude Kit within weeks of the virus reaching Singapore’s shores.
Jingmei Li is developing a risk scoring system for breast cancer that could help clinicians formulate better screening programs to catch the disease in its early stages.
A*STAR researchers have devised a method that can detect and distinguish closely related flaviviruses with 100 percent accuracy.
Proteomics expert Ruedi Aebersold discusses the use of multiplex targeted mass spectrometry for one-shot flavivirus diagnosis.
Using an expanded genetic alphabet containing fluorescent artificial DNA bases, scientists can now visually detect and quantify DNA molecules for use in diagnostics.
Diagnostic tests are the key to the early detection and treatment of
diseases — and Singapore’s Diagnostics Development (DxD) Hub is accelerating the rate at which devices make it from the lab to market.